CTSG
Cathepsin G
Also known as: CATG_HUMAN, CG
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08311
- Gene
- CTSG
- Ensembl
- ENSG00000100448
- Chromosome
- 14
- Canonical length
- 255 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene, a member of the peptidase S1 protein family, is found in azurophil granules of neutrophilic polymorphonuclear leukocytes. The encoded protease has a specificity similar to that of chymotrypsin C, and may participate in the killing and digestion of engulfed pathogens, and in connective tissue remodeling at sites of inflammation. In addition, the encoded protein is antimicrobial, with bacteriocidal activity against S. aureus and N. gonorrhoeae. Transcript variants utilizing alternative polyadenylation signals exist for this gene. [provided by RefSeq, Sep 2014]
Canonical amino-acid sequenceUniProt
255 residues, UniProt reviewed canonical sequence.
>P08311|CTSG
1 MQPLLLLLAF LLPTGAEAGE IIGGRESRPH SRPYMAYLQI QSPAGQSRCG GFLVREDFVL
61 TAAHCWGSNI NVTLGAHNIQ RRENTQQHIT ARRAIRHPQY NQRTIQNDIM LLQLSRRVRR
121 NRNVNPVALP RAQEGLRPGT LCTVAGWGRV SMRRGTDTLR EVQLRVQRDR QCLRIFGSYD
181 PRRQICVGDR RERKAAFKGD SGGPLLCNNV AHGIVSYGKS SGVPPEVFTR VSSFLPWIRT
241 TMRSFKLLDQ METPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTSG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 5,049 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 5,049 nTPM
- urinary bladder: 33 nTPM
- skin: 25 nTPM
- gallbladder: 24 nTPM
- thymus: 24 nTPM
- rectum: 24 nTPM
Single-cell type
- mast cells: 835 nCPM
- neutrophil progenitors: 545 nCPM
- monocyte progenitors: 144 nCPM
- late spermatids: 14 nCPM
- hematopoietic stem cells: 7.3 nCPM
- late primary spermatocytes: 5.2 nCPM
Immune cell
- total PBMC: 19 nTPM
- neutrophil: 7.3 nTPM
- plasmacytoid DC: 6.6 nTPM
- classical monocyte: 6 nTPM
- myeloid DC: 5.4 nTPM
- NK-cell: 5.1 nTPM
Brain region
- basal ganglia: 0.1 nTPM
- cerebral cortex: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- midbrain: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CTSG.
Disease | ImmuneIEDB
Conditions an epitope on CTSG was assayed in.
- acute myeloid leukemia T cell
ReferencesPubMed · IEDB
Publications for CTSG from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
14 publications
- Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.
1992 · Clin Exp Immunol · RCR 4.3 · 135 citations - Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus.
2003 · J Rheumatol · RCR 2.6 · 119 citations - Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.
1998 · Am J Med · RCR 1.3 · 44 citations - Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis.
1998 · Nephrol Dial Transplant · RCR 1.1 · 42 citations - Antibodies to cathepsin G in Crohn's disease.
1992 · Eur J Clin Invest · RCR 1 · 25 citations
Show 9 more
- Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis.
1998 · Arch Dis Child · RCR 0.6 · 19 citations - Circulating granulocyte antibodies in first attacks of colitis.
1995 · Scand J Gastroenterol · RCR 0.5 · 14 citations - Elevated antilysosomal-associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura.
2012 · Br J Dermatol · RCR 0.4 · 13 citations - Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis.
2000 · J Gastroenterol · RCR 0.3 · 12 citations - Antibodies to human myeloperoxidase in glomerular immune deposits of systemic lupus erythematosus.
2000 · Lupus · RCR 0.2 · 7 citations - Methods of detection of anti-cathepsin G autoantibodies in human.
1993 · Adv Exp Med Biol · RCR 0.2 · 4 citations - Human mononuclear cells and neutral proteinases. III. Neutral proteinases and rheumatoid arthritis: monocytes as a source of cathepsin G and proteinase potentiation of IgM rheumatoid factor elaboration.
1989 · Inflammation · RCR 0.1 · 2 citations - [Prevalence and clinical significance of cathepsin G antibodies in systemic sclerosis].
2003 · Reumatismo · RCR 0 · 1 citations - [Wegener's granulomatosis with anti-neutrophil cytoplasmic antibodies against anti-cathepsin G antigen].
2013 · An Pediatr (Barc)
Reference: T cellIEDB
1 publication
- A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.
2013 · Clin Cancer Res · RCR 0.6 · 24 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiotensin maturation
- antibacterial humoral response
- cellular response to lipopolysaccharide
- cytokine-mediated signaling pathway
- defense response to fungus
- defense response to Gram-negative bacterium
- defense response to Gram-positive bacterium
- extracellular matrix disassembly
- immune response
- monocyte chemotaxis
- negative regulation of T cell activation
- neutrophil activation
- neutrophil-mediated killing of gram-positive bacterium
- platelet activation
- positive regulation of immune response
- positive regulation of platelet aggregation
- protein maturation
- protein processing
- proteolysis
- purinergic nucleotide receptor signaling pathway
- biofilm matrix disassembly
Molecular functions
- caspase binding
- heparin binding
- peptidase activity
- receptor ligand activity
- serine-type endopeptidase activity
- serine-type peptidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CTSG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTSG as an antibody target. Whether an autoantibody or antibody against CTSG could matter depends on whether native CTSG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTSG is annotated at the cell surface, where native CTSG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CTSG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...